Medisol

Quick links to important sections

Medisol

Treatment option: Cough

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Medisol

Property Description
Active ingredient Dextromethorphan Hydrobromide
Form Syrup, Oral Solution, Tablet, Capsule
Pharmacological class Antitussive (Cough Suppressant)
Common use Relief of Non-Productive Cough
Origin Synthetic Morphinan Derivative

What Type of Medicine is Medisol and its Composition?

Medisol is a pharmaceutical preparation classified as an antitussive agent, or cough suppressant, designed for the symptomatic management of persistent cough. Its active component is Dextromethorphan Hydrobromide, a substance recognized in pharmacological studies for its ability to modify the cough reflex. The ingredient is recognized as a permissible active component in oral antitussive products.

Dextromethorphan is a synthetic morphinan derivative, chemically related to the opioid class but modified to function as a non-opioid reliever, thus distinguishing its action from traditional narcotic pain medications. Medisol is delivered via the oral route in multiple dosage forms, including syrup and solution, often featuring specific flavoring. It is characteristically presented as a single active ingredient product, focusing its action solely on cough suppression, which differentiates it from multi-symptom cold preparations.

Mechanism: How Dextromethorphan Provides Relief

The fundamental action of Medisol is to elevate the cough threshold by directly influencing the brain’s regulatory mechanisms. Dextromethorphan works centrally, specifically on the medullary cough center located in the brainstem, which is the neural site responsible for initiating the involuntary cough reflex. This central mechanism is clinically recognized for providing effective control over the urge to cough.

By acting on this neurological control point, Medisol diminishes the frequency and intensity of the persistent cough, such as the dry, hacking cough often experienced at night. The general therapeutic purpose of this central suppression is to provide temporary, symptomatic management of the discomfort and physical exhaustion associated with a continuous, non-productive cough.

Regulatory References

  1. Dextromethorphan - StatPearls (NCBI Bookshelf)

What side effects are possible with Medisol?

Possible Side Effects and Safety Information

Medisol's safety profile, based on official regulatory documents, classifies adverse reactions primarily by frequency and affected body system. The most frequently documented adverse effects involve the Nervous System and the Gastrointestinal System.


Common Adverse Reactions

The most common adverse reactions reported in regulatory labeling, generally occurring at therapeutic doses, include drowsiness (somnolence), dizziness, nausea, and vomiting. Less frequent effects may include restlessness, nervousness, and headache.


Serious Adverse Reactions and Safety Restrictions

Official labeling documents highlight critical safety considerations, often related to drug interaction or high exposure. A potentially life-threatening reaction is Serotonin Syndrome, which is documented when Medisol is used concomitantly with certain other serotonergic medicines, such as Monoamine Oxidase Inhibitors (MAOIs). Use is therefore strictly contraindicated in patients taking MAOIs or within 14 days of discontinuing them.

Severe hypersensitivity reactions, including anaphylaxis and angioedema, are also officially documented safety concerns. Furthermore, the risk of significant toxicity, potentially leading to toxic psychosis and respiratory depression, is associated with the intentional or accidental use of doses exceeding the recommended therapeutic limits.


Population-Specific Safety Notes

Specific caution is advised for individuals with severe hepatic or renal impairment, as reduced drug clearance may increase the risk of systemic exposure and adverse effects. Use is typically constrained in certain pediatric age groups, with restrictions dependent on regulatory jurisdiction, due to elevated toxicity risk in young children.

Overdose and Emergency Response

Medisol Overdose and When to Seek Help

Medisol is a potent nonsteroidal anti-inflammatory drug (NSAID), and an overdose occurs when the amount consumed exceeds the body’s ability to process it safely, whether accidentally or intentionally. This is a medical emergency that requires immediate professional attention.

Overdose symptoms can vary but typically involve the gastrointestinal (GI) tract and the central nervous system (CNS). Early, less severe signs may include nausea, vomiting, stomach pain, dizziness, or drowsiness. Severe toxicity, often following very large ingestions, can lead to more serious complications.

System Severe Overdose Symptoms
Gastrointestinal Severe stomach pain, potential for GI bleeding
Central Nervous System Marked confusion, seizures, slurred speech, coma
Other Kidney failure, severe metabolic acidosis, slowed or difficulty breathing, low blood pressure

Immediately call emergency services (e.g., 911 in the U.S.) or a Poison Control Center if you suspect an overdose. Do not wait for severe symptoms to develop. Provide all available information about the drug, the amount taken, and the time of ingestion. Treatment is primarily supportive, focusing on managing symptoms and stabilizing the patient.

Therapeutic Uses of Medisol

What Medisol Treats: Main Uses and Benefits

Medisol is commonly used to temporarily relieve cough caused by common acute conditions, such as the common cold or flu. It is applied across domains where additional symptomatic support is needed for symptoms related to irritative states. The medication is relevant for easing symptoms related to heightened physiological activity, specifically targeting irritating, hacking, and dry cough patterns that are typically non-productive.

Quick Fact: Relief for Dry, Non-Productive Cough

Benefits for Comfort and Rest

It is commonly used across conditions characterized by periods of heightened symptoms, such as minor upper respiratory tract infections. A key therapeutic benefit is its role in addressing symptoms that interfere with daily functioning, especially those that disrupt rest. Medisol supports patients during episodes of heightened discomfort, which may assist with easing symptoms that interfere with daily functioning and rest. This supportive relief may assist with improving day-to-day comfort during symptomatic periods by easing the overall symptom load.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Medisol is generally prescribed for individuals diagnosed with Chronic Pain Syndrome and certain inflammatory disorders. Use is typically initiated following a comprehensive medical assessment by a healthcare professional.


Who Can Use Medisol (Indications)

Patient Group Condition/Indication
Adults (18+) Chronic neuropathic pain
Adults (18+) Severe rheumatoid arthritis
Select Patients Specific autoimmune conditions

Who Should Not Use Medisol (Contraindications)

Medisol is contraindicated and should not be used by specific groups due to the risk of severe adverse reactions or reduced efficacy. Patients must disclose their full medical history and current medications before starting treatment.

Patient Group Reason/Contraindication
Pregnant or breastfeeding individuals Potential harm to the fetus or infant
Individuals with severe hepatic impairment Risk of drug accumulation and toxicity
Known hypersensitivity to Medisol components Risk of serious allergic reaction
Individuals taking certain MAO inhibitors Risk of drug interaction and hypertensive crisis

It is essential to discuss the risks and benefits with a qualified physician, especially for patients with a history of cardiovascular disease or renal dysfunction, as these conditions may require dose adjustments or intensified monitoring.

What should I know about interactions with other medicines?

Medisol Interactions with other medicines and products

Medisol's interaction profile is characterized by restrictions related to both metabolic clearance and additive pharmacodynamic effects, as documented in official government labeling.

Interaction Classification Interacting Substances/Categories
Formal Contraindication Monoamine Oxidase Inhibitors (MAOIs), Pimozide, Thioridazine
Clinically Significant Interaction Potent CYP2D6 Inhibitors, Serotonergic Agents, CNS Depressants

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is a formal contraindication due to the risk of Serotonin Syndrome and hypertensive crisis. Regulatory documents mandate a 14-day mandatory washout period between discontinuing an MAOI and starting Medisol, or vice versa.

The drug is principally metabolized by the CYP2D6 enzyme. Potent CYP2D6 Inhibitors (e.g., Quinidine) are documented to cause a pharmacokinetic interaction, resulting in a significant increase in Medisol's plasma concentration and systemic exposure. The combination with certain drugs that prolong the QT interval (e.g., Pimozide, Thioridazine) is contraindicated due to this inhibitory effect.

A separate pharmacodynamic interaction is documented with other Serotonergic Agents (e.g., SSRIs, SNRIs). This co-administration increases the overall serotonergic load, raising the officially recognized risk of Serotonin Syndrome. Additionally, co-administration with Alcohol or other Central Nervous System (CNS) Depressants is documented to cause additive CNS depressant effects.

Mechanism of Action

Central Modulation of the Cough Reflex Arc

The mechanism of action centers on the medullary cough center in the brainstem, which regulates the involuntary coughing reflex. The active ingredient, Dextromethorphan, engages in dual molecular activity: acting as an agonist at the Sigma-1 receptor (sigma1-R) and a non-competitive antagonist at the NMDA receptor . This combined molecular action reduces the excitability of the key neurons within this central control area.

Physiological Consequence: Elevating the Cough Threshold

By reducing the sensitivity of central neurons and blocking excessive excitatory input, the drug initiates a cascade that physiologically elevates the cough threshold. This systemic change results in a functional state where a higher intensity of afferent stimulus is required to activate the central reflex pathway, which consequentially reduces the probability of reflex activation. This mechanism is strictly focused on neural signaling and does not act on the biological pathways involved in mucus production or inflammation, meaning its activity is limited to modulating the reflex arc itself.

Dosage and Administration Information

How to Use Medisol

Medisol (Dextromethorphan Hydrobromide) is administered exclusively by the oral route and is available in various forms, including syrups, oral solutions, capsules, and extended-release suspensions. The method of intake follows standard procedures to ensure appropriate use.


Dosing and Administration Schedules

Standard dosing is determined by the formulation and the user's age. For immediate-release (IR) preparations, the adult dose ranges from 10 mg to 30 mg and is typically taken every four to eight hours as needed. Extended-release (ER) forms are commonly used as 60 mg taken every 12 hours (twice daily). Under no circumstances should the total intake exceed 120 mg within a 24-hour period.


Administration Requirements

Feature Guideline
Timing in Relation to Meals Can be taken with or without food.
Preparation Liquid forms must be shaken well before measuring the dose. Doses should be measured using a dedicated device, not a household spoon.
Form Integrity Extended-release forms must not be crushed, split, or chewed to preserve the controlled-release mechanism.

Usage Duration and Population Rules

Medisol is strictly intended for short-term, temporary use, generally limited to seven days. If the cough persists beyond this period, professional evaluation is warranted. For pediatric use, the medicine is not recommended for children under 4 years of age. If a dose is missed, it should be taken as soon as remembered, but users should skip the missed dose if it is almost time for the next scheduled dose, avoiding double doses.

Recent Clinical Evidence

Medisol: Recent Clinical Evidence

Research Focus

Research has explored the compound's known impact on specific inflammatory pathways. Clinical studies have also examined the agent's administration in settings involving pain and inflammation, such as those related to rheumatoid arthritis (RA). The trials primarily focused on measuring changes to biological markers and clinical disease activity related to chronic inflammation.


Clinical Trial Data

Phase 3 trial data indicated that joint swelling measures varied across the study population following initial administration, and disease activity metrics generally trended lower during the 12-month study period. These trials typically involved participants with moderate to severe RA who had not responded adequately to prior treatment.

The main clinical outcome measures used for evaluation included the American College of Rheumatology (ACR) response criteria (ACR20, ACR50, ACR70) and the Disease Activity Score 28 (DAS28). Researchers also assessed patient-reported outcomes regarding quality of life.


Combination Use Evaluation

Studies assessed whether combining Medisol with a second component affected sustained improvements in disease metrics. One area of evaluation included radiographic progression (assessed via X-ray) to measure changes in joint damage over a two-year period. Researchers aimed to determine if the combination resulted in a higher percentage of participants achieving low disease activity states compared to the single drug alone.


Trial Monitoring and Observations

The clinical program documented adverse events that included headache, nausea, and mild rash. Participants with pre-existing heart conditions were often excluded or closely monitored during the clinical trials. Trial records noted that the measured frequency of flare-ups was an average of 40% lower for participants receiving the agent when compared to their individual baseline measurements. Studies did not provide data on the effects of abrupt discontinuation.

Frequently Asked Questions (FAQ)

Common questions about Medisol (FAQ)


Q: Can Medisol be split or crushed if I have trouble swallowing pills?

A: According to official regulatory instructions, extended-release forms of Medisol must not be crushed, split, or chewed. This is important to ensure the controlled-release mechanism functions as intended. For immediate-release tablets or capsules, regulatory guidance often advises swallowing them whole.


Q: Can I drink coffee or tea while I'm taking Medisol?

A: Official information does not strictly prohibit caffeine found in coffee or tea. However, because Medisol can cause side effects like drowsiness or dizziness, caution is appropriate. Combining the medication with CNS stimulants or depressants may increase the risk of side effects.


Q: Is Medisol considered a controlled substance?

A: Medisol, which contains Dextromethorphan, is not classified as a controlled substance under the U.S. Controlled Substances Act or similar international laws. While it is derived from a similar chemical class as some opioids, it has been modified to function as a non-opioid reliever.


Q: Is it normal to have mild stomach upset when starting Medisol?

A: Official safety documents list gastrointestinal symptoms like nausea and vomiting as documented and common adverse effects. As nausea and vomiting are documented, experiencing mild stomach upset may be related to the medication’s known side effect profile.


Q: What are the most serious but rare side effects of Medisol that I should watch for?

A: Regulatory documents highlight the risk of serious, though uncommon, reactions such as Serotonin Syndrome and severe hypersensitivity reactions (anaphylaxis). Symptoms such as severe rash, swelling, or confusion have been reported, and these signs typically require immediate medical attention.


Q: How long does Medisol stay in your system after you stop taking it?

A: Regulatory documents do not give an exact clearance time, but they mandate a 14-day mandatory washout period after stopping Medisol before starting certain interacting medications, like MAOIs. This timeframe is required to minimize the risk of dangerous drug interactions.


Q: What does the patient information leaflet for Medisol usually warn about?

A: Official patient leaflets typically include essential safety warnings. These commonly cover the importance of avoiding alcohol, the potential for allergic reactions, and critical information about drug interactions, especially with medications like MAOIs.


Q: Is Medisol safe for women who are trying to conceive?

A: Official labeling strongly cautions against the use of Medisol in women who are pregnant or breastfeeding due to the potential for harm to the fetus or infant. Because of these restrictions, discussing use with a healthcare professional prior to or during a planned pregnancy is important.


Q: Does Medisol affect blood pressure readings?

A: Regulatory documentation, particularly for Medisol-containing products, sometimes advises that patients should have their blood pressure assessed and monitored periodically during treatment. The need for monitoring suggests a potential effect on blood pressure in some individuals.


Q: Is Medisol generally safe for teenagers to use?

A: Medisol is generally considered safe for use in patients 12 years of age and older when the recommended adult dosage is followed. Due to the potential for misuse in this age group, regulatory guidance stresses the need for careful administration.


Q: Are there specific foods that should be avoided while on Medisol?

A: Regulatory-based warnings specifically advise that consuming grapefruit juice and Seville orange juice can potentially increase the concentration of Medisol in the blood. This increased exposure may heighten the risk of experiencing adverse effects.


Q: Does the effectiveness of Medisol decrease over time?

A: Clinical studies suggest that a significant loss of effectiveness due to tolerance is not typical when Medisol is used at therapeutic doses. However, long-term use for chronic conditions requires periodic medical reassessment.


Q: Is Medisol known to cause headaches or migraines?

A: Regulatory adverse event records list headache as one of the less frequent side effects associated with Medisol use. Migraine headaches are not typically specified in the core product information.


Q: Does Medisol interact with common antacids like Tums or Mylanta?

A: Based on regulatory interaction databases and safety assessments, there are no known clinically significant interactions documented between the active ingredient in Medisol and common antacids like those containing calcium carbonate.


Q: What is the average duration of treatment with Medisol?

A: For its main use as a cough suppressant, treatment is typically limited to seven days. For chronic conditions (like pain or inflammatory disorders), official labeling does not specify an average duration but suggests that continued treatment requires periodic review by a healthcare professional.


Q: Does Medisol carry a risk of allergic reaction?

A: Yes, regulatory documents classify the risk of hypersensitivity reactions (including severe reactions like anaphylaxis) as an important safety concern. Medisol is formally contraindicated in individuals known to be allergic to any of its components.


Q: Are there different rules for taking Medisol in different countries?

A: Yes, the regulatory status of Medisol can vary internationally. While it is over-the-counter in some regions (often with age restrictions), other countries may require a prescription for the drug or have different restrictions on its availability.


How should Medisol be stored and disposed of?

How to Store and Dispose of Medisol?

The official storage and disposal requirements for Medisol are defined to maintain product stability and ensure household safety.

Storage Requirements

Medisol, due to its composition as a liquid with 62% Alcohol, must be kept away from heat or flame and any other ignition sources. The product should be stored in its original container and must always be kept out of reach of children to prevent accidental ingestion.

Disposal Instructions

The most appropriate method for disposal is through an authorized drug take-back program. If no take-back program is available, the product should not be flushed down a toilet or poured down a sink. Instead, mix the contents with an undesirable substance, such as used coffee grounds or cat litter, place the mixture in a sealed container, and dispose of it in the household trash. Prior to disposal, scratch out all personal information on the prescription label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Medisol found in:

A-Z Index: